Literatur
Kramer S, Gelber RD, Snow JB et al (1987) Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10:19–30
Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081–2086
Szczesniak MM, Maclean J, Zhang T et al (2014) Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality. Clin Oncol (R Coll Radiol) 26:697–703
Nutting C, Finneran L, Roe J et al (2023) Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial. Lancet Oncol 24:868–880
Hutcheson KA, Barrow MP, Lisec A et al (2016) What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients? Laryngoscope 126:1108–1113
Carlsson S, Rydén A, Rudberg I et al (2012) Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer and neurologic swallowing disturbances. Dysphagia 27:361–369
Mogadas S, Busch CJ, Pflug C et al (2020) Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma. Strahlenther Onkol 196:522–529
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A.M. Ziebolz gibt an, dass kein Interessenkonflikt besteht.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
Originalpublikation
Nutting C, Finneran L, Roe J et al (2023) Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial. Lancet Oncol 24:868–880.
Rights and permissions
About this article
Cite this article
Ziebolz, A.M. Verbesserte Schluckfunktion nach definitiver Radiochemotherapie bei Oro- und Hypopharynxkarzinomen durch Schonung der Musculi constrictores pharyngis. Strahlenther Onkol 200, 361–363 (2024). https://doi.org/10.1007/s00066-024-02212-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-024-02212-y